This compound is primarily utilized in the field of medicinal chemistry as a key intermediate or building block for the synthesis of more complex molecules, particularly those targeting neurological disorders. Its structure, featuring a trifluoromethoxy phenyl group and a pyrrolidine ring, makes it valuable in the development of drugs that interact with central nervous system receptors. It is often explored in the design of potential therapeutics for conditions such as depression, anxiety, and chronic pain due to its ability to modulate neurotransmitter systems. Additionally, its chiral nature allows for the creation of enantiomerically pure compounds, which can enhance specificity and reduce side effects in drug candidates. Researchers also investigate its role in optimizing pharmacokinetic properties, such as bioavailability and metabolic stability, in early-stage drug discovery.